Cargando…
Impact of SARS-CoV-2 AstraZeneca Vaccine on Safety and Blood Elements of Egyptian Healthcare Workers
BACKGROUND: Many coronavirus disease 2019 (COVID-19) vaccines were approved worldwide. Their safety was the primary concern. In Egypt, Oxford–AstraZeneca (AZ) vaccine was the first approved vaccine initially for healthcare workers (HCWs). OBJECTIVE: We aim to determine adverse events and hematologic...
Autores principales: | Meshref, Taghreed S., Hamad, Dina A., Aly, Mai M., Kamal, Dalia T., Elkhayat, Mariam R., Elghazally, Shimaa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691519/ https://www.ncbi.nlm.nih.gov/pubmed/38047168 http://dx.doi.org/10.4103/ijoem.ijoem_275_22 |
Ejemplares similares
-
AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia
Publicado: (2021) -
Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
Publicado: (2021) -
Vaccin Oxford/AstraZeneca, mode d’emploi
por: Dalmat, Yann-Mickael
Publicado: (2021) -
Oxford–AstraZeneca COVID-19 vaccine efficacy
por: Knoll, Maria Deloria, et al.
Publicado: (2021) -
AstraZeneca COVID-19 vaccine-related thromboembolism
Publicado: (2021)